Moneycontrol PRO
remdesivir injection
Jump to
1 Results Found
  • Nifty Q1 preview | COVID factor set to boost Cipla’s results Aug 04, 2021 01:33 PM IST

    Nifty Q1 preview | COVID factor set to boost Cipla’s results

    Pharmaceutical major and Nifty heavyweight Cipla will report its earnings report for Q1FY22 on August 5, 2021. Our poll expects the company to benefit significantly from Covid-led demand during the June quarter. Here’s a detailed preview of what to expect

Sections
ISO 27001 - BSI Assurance Mark